SANOFICONR Stock Overview
Operates as a fast-moving consumer healthcare company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Sanofi Consumer Healthcare India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,789.75 |
| 52 Week High | ₹5,375.00 |
| 52 Week Low | ₹4,211.55 |
| Beta | 0 |
| 11 Month Change | 0.82% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| SANOFICONR | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.6% | 0.5% | 0.5% |
| 1Y | n/a | 42.5% | 27.5% |
Return vs Industry: Insufficient data to determine how SANOFICONR performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SANOFICONR performed against the Indian Market.
Price Volatility
| SANOFICONR volatility | |
|---|---|
| SANOFICONR Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: SANOFICONR has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine SANOFICONR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | n/a | Himanshu Bakshi | www.sanofi.in/en/Consumer-Healthcare/health-and-well-being |
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, Baralgan, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India.
Sanofi Consumer Healthcare India Limited Fundamentals Summary
| SANOFICONR fundamental statistics | |
|---|---|
| Market cap | ₹110.31b |
| Earnings (TTM) | ₹392.50m |
| Revenue (TTM) | ₹2.31b |
281.0x
P/E Ratio47.7x
P/S RatioIs SANOFICONR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SANOFICONR income statement (TTM) | |
|---|---|
| Revenue | ₹2.31b |
| Cost of Revenue | ₹532.00m |
| Gross Profit | ₹1.78b |
| Other Expenses | ₹1.39b |
| Earnings | ₹392.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 17.04 |
| Gross Margin | 77.01% |
| Net Profit Margin | 16.96% |
| Debt/Equity Ratio | 10.9% |
How did SANOFICONR perform over the long term?
See historical performance and comparison